These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 27122198

  • 1. Investigational therapies for renal disease-induced anemia.
    Schmid H, Jelkmann W.
    Expert Opin Investig Drugs; 2016 Aug; 25(8):901-16. PubMed ID: 27122198
    [Abstract] [Full Text] [Related]

  • 2. Investigational hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHI) for the treatment of anemia associated with chronic kidney disease.
    Del Vecchio L, Locatelli F.
    Expert Opin Investig Drugs; 2018 Jul; 27(7):613-621. PubMed ID: 29975110
    [Abstract] [Full Text] [Related]

  • 3. Will there still be a role for the originator erythropoiesis-simulating agents after the biosimilars and the hypoxia-inducible factor stabilizers approval?
    Locatelli F, Del Vecchio L.
    Curr Opin Nephrol Hypertens; 2018 Sep; 27(5):339-344. PubMed ID: 29846220
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Emerging drugs for the treatment of kidney disease-induced anemia.
    Malyszko J, Malyszko JS.
    Expert Opin Emerg Drugs; 2016 Sep; 21(3):315-30. PubMed ID: 27537859
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. New Treatment Approaches for the Anemia of CKD.
    Bonomini M, Del Vecchio L, Sirolli V, Locatelli F.
    Am J Kidney Dis; 2016 Jan; 67(1):133-42. PubMed ID: 26372086
    [Abstract] [Full Text] [Related]

  • 8. Peginesatide for the treatment of renal disease-induced anemia.
    Schmid H.
    Expert Opin Pharmacother; 2013 May; 14(7):937-48. PubMed ID: 23506424
    [Abstract] [Full Text] [Related]

  • 9. Experimental and investigational therapies for chemotherapy-induced anemia.
    Testa U, Castelli G, Elvira P.
    Expert Opin Investig Drugs; 2015 May; 24(11):1433-45. PubMed ID: 26359222
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, Kuriyama S, Komatsu Y, Suzuki M, Nakai S, Hattori M, Babazono T, Hiramatsu M, Yamamoto H, Bessho M, Akizawa T.
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [Abstract] [Full Text] [Related]

  • 13. Anemia in chronic kidney disease.
    Atkinson MA, Warady BA.
    Pediatr Nephrol; 2018 Feb; 33(2):227-238. PubMed ID: 28412770
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesis.
    Rainville N, Jachimowicz E, Wojchowski DM.
    Expert Opin Ther Targets; 2016 Feb; 20(3):287-301. PubMed ID: 26419263
    [Abstract] [Full Text] [Related]

  • 16. Managing Anemia across the Stages of Kidney Disease in Those Hyporesponsive to Erythropoiesis-Stimulating Agents.
    Weir MR.
    Am J Nephrol; 2021 Feb; 52(6):450-466. PubMed ID: 34280923
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Iron Metabolism in Chronic Kidney Disease Patients.
    Honda H, Hosaka N, Ganz T, Shibata T.
    Contrib Nephrol; 2019 Feb; 198():103-111. PubMed ID: 30991401
    [Abstract] [Full Text] [Related]

  • 19. Novel Masters of Erythropoiesis: Hypoxia Inducible Factors and Recent Advances in Anemia of Renal Disease.
    Solak Y, Cetiner M, Siriopol D, Tarim K, Afsar B, Covic A, Kanbay M.
    Blood Purif; 2016 Feb; 42(2):160-7. PubMed ID: 27318465
    [Abstract] [Full Text] [Related]

  • 20. Emerging drugs for treatment of anemia of chronic kidney disease.
    Magwood JS, Lebby A, Chen B, Kessler S, Norris L, Bennett CL.
    Expert Opin Emerg Drugs; 2013 Dec; 18(4):421-9. PubMed ID: 24033253
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.